Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ophthalmic firm Alimera Sciences closes $26.75mm Series A round

Executive Summary

Alimera Sciences (specializes in ophthalmic pharmaceuticals) raised $26.75mm with its Series A financing led by Intersouth Partners. BA Venture Partners, Domain Associates, and Polaris Venture Partners also participated. All investors made equal contributions to the round.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies